Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-23-007871
Filing Date
2023-03-14
Accepted
2023-03-14 16:16:17
Documents
86
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K kzr-20221231.htm   iXBRL 10-K 3586883
2 EX-10.20 kzr-ex10_20.htm EX-10 78621
3 EX-23.1 kzr-ex23_1.htm EX-23 2907
4 EX-31.1 kzr-ex31_1.htm EX-31 19124
5 EX-31.2 kzr-ex31_2.htm EX-31 18956
6 EX-32.1 kzr-ex32_1.htm EX-32 12986
7 GRAPHIC img38338535_0.jpg GRAPHIC 80927
8 GRAPHIC img141614612_0.jpg GRAPHIC 115725
9 GRAPHIC img141614612_1.jpg GRAPHIC 63301
  Complete submission text file 0000950170-23-007871.txt   13467763

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT kzr-20221231_cal.xml EX-101.CAL 58299
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kzr-20221231.xsd EX-101.SCH 71170
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT kzr-20221231_def.xml EX-101.DEF 222774
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kzr-20221231_pre.xml EX-101.PRE 423454
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kzr-20221231_lab.xml EX-101.LAB 574116
80 EXTRACTED XBRL INSTANCE DOCUMENT kzr-20221231_htm.xml XML 2780735
Mailing Address 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-822-5600
Kezar Life Sciences, Inc. (Filer) CIK: 0001645666 (see all company filings)

EIN.: 473366145 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38542 | Film No.: 23731190
SIC: 2834 Pharmaceutical Preparations